PFE Pfizer Inc.

PFE Pfizer Inc.

Healthcare · Drug Manufacturers - General

Market read

Scan convergence 1 scan as of 2026-10-16 1 bull converging

POC $25.58 · VWAP $26.00 · +13.8% vs 12m avg buyer

uptrend vol: compressedchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CEO, Director + 1 other bought $3M, Aug 5–12

Coverage

1 related campaign

PFE Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PFE belongs to, members best 30-day change first — PFE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@healthcare-scan
@healthcare

Next earnings PFE reports in 17 days Nov 3

Last report Aug 4

Pfizer's second-quarter results beat earnings expectations, helped by strong demand for its blood-thinner portfolio, per Reuters (Aug 4 news pull). The company also outlined an additional $2.5 billion in cost cuts to support margins amid ongoing post-pandemic revenue pressure.

full note →

Against street estimates

How PFE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Oct 16

Result
Aug 4 0.680.77 GAAP ≠ +12.9%Beat
May 5 0.720.75 GAAP ≠ +3.9%Beat
Feb 3 0.570.66+16.2%Beat
Nov 4 '25 0.630.87 GAAP ≠ +37.4%Beat
Aug 5 '25 0.570.78 GAAP ≠ +35.9%Beat
Apr 29 '25 0.670.92 GAAP ≠ +36.5%Beat
Feb 4 '25 0.460.63+37.2%Beat
Oct 29 '24 0.611.06 GAAP ≠ +73.3%Beat
Types
Aug 5 The Prints The Prints
Aug 4 Catalyst PFE earnings
PFE
May 5 Catalyst PFE earnings
PFE